BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17177746)

  • 1. The combination of 2% 4-hydroxyanisole (mequinol) and 0.01% tretinoin effectively improves the appearance of solar lentigines in ethnic groups.
    Draelos ZD
    J Cosmet Dermatol; 2006 Sep; 5(3):239-44. PubMed ID: 17177746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of 2% 4-hydroxyanisole (Mequinol) and 0.01% tretinoin is effective in improving the appearance of solar lentigines and related hyperpigmented lesions in two double-blind multicenter clinical studies.
    Fleischer AB; Schwartzel EH; Colby SI; Altman DJ
    J Am Acad Dermatol; 2000 Mar; 42(3):459-67. PubMed ID: 10688717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines.
    Ortonne JP; Camacho F; Wainwright N; Bergfelt L; Westerhof W; Roseeuw D
    Cutis; 2004 Oct; 74(4):261-4. PubMed ID: 15551721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mequinol 2%/tretinoin 0.01% solution: an effective and safe alternative to hydroquinone 3% in the treatment of solar lentigines.
    Jarratt M
    Cutis; 2004 Nov; 74(5):319-22. PubMed ID: 15605971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A promising new treatment for solar lentigines.
    Colby SI; Schwartzel EH; Huber FJ; Highton A; Altman DJ; Epinette WW; Lyon E
    J Drugs Dermatol; 2003 Apr; 2(2):147-52. PubMed ID: 12852366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytic quantification of the bleaching effect of a 4-hydroxyanisole-tretinoin combination on actinic lentigines.
    Piérard-Franchimont C; Henry F; Quatresooz P; Vroome V; Piérard GE
    J Drugs Dermatol; 2008 Sep; 7(9):873-8. PubMed ID: 19112802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mequinol 2%/tretinoin 0.01% topical solution for the treatment of melasma in men: a case series and review of the literature.
    Keeling J; Cardona L; Benitez A; Epstein R; Rendon M
    Cutis; 2008 Feb; 81(2):179-83. PubMed ID: 18441773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption of [3H]tretinoin and systemic exposure to mequinol after dermal application of 2% mequinol/0.01% [3H]tretinoin (Solagé) solution in healthy volunteers.
    Everett DW; Franz TJ; Chando TJ; Gale PJ; Lehman PA; Schwarzel EH; Parab PV; D'Arienzo CJ; Kripalani KJ
    Biopharm Drug Dispos; 1999 Sep; 20(6):301-8. PubMed ID: 10701701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination therapy for solar lentigines.
    Farris PK
    J Drugs Dermatol; 2004; 3(5 Suppl):S23-6. PubMed ID: 15552596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-strength tretinoin for rapid retinization of photoaged facial skin.
    Kligman DE; Draelos ZD
    Dermatol Surg; 2004 Jun; 30(6):864-6. PubMed ID: 15171763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cryotherapy vs. trichloroacetic acid in the treatment of solar lentigo.
    Raziee M; Balighi K; Shabanzadeh-Dehkordi H; Robati RM
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):316-9. PubMed ID: 18021205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical agents for the aging face.
    Scully K
    J Cutan Med Surg; 1999 Dec; 3 Suppl 4():S1-6. PubMed ID: 11749893
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
    Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
    Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical tretinoin (retinoic acid) treatment for liver spots associated with photodamage.
    Rafal ES; Griffiths CE; Ditre CM; Finkel LJ; Hamilton TA; Ellis CN; Voorhees JJ
    N Engl J Med; 1992 Feb; 326(6):368-74. PubMed ID: 1729619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical tretinoin (retinoic acid) improves early stretch marks.
    Kang S; Kim KJ; Griffiths CE; Wong TY; Talwar HS; Fisher GJ; Gordon D; Hamilton TA; Ellis CN; Voorhees JJ
    Arch Dermatol; 1996 May; 132(5):519-26. PubMed ID: 8624148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 4 study to assess tretinoin pump for the treatment of facial acne.
    Eichenfield LF; Nighland M; Rossi AB; Cook-Bolden F; Grimes P; Fried R; Levy S;
    J Drugs Dermatol; 2008 Dec; 7(12):1129-36. PubMed ID: 19137766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin.
    Humphreys TR; Werth V; Dzubow L; Kligman A
    J Am Acad Dermatol; 1996 Apr; 34(4):638-44. PubMed ID: 8601654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical study of a retinoic acid-loaded microneedle patch for seborrheic keratosis or senile lentigo.
    Hirobe S; Otsuka R; Iioka H; Quan YS; Kamiyama F; Asada H; Okada N; Nakagawa S
    Life Sci; 2017 Jan; 168():24-27. PubMed ID: 26757104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin versus 20% glycolic acid/10% L-ascorbic acid).
    Ash K; Lord J; Zukowski M; McDaniel DH
    Dermatol Surg; 1998 Aug; 24(8):849-56. PubMed ID: 9723049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.